第一单位：
Vaccine Research Institute, Université Paris-Est Créteil, Faculté de Médecine, INSERM U955, équipe 16, Créteil, France.;Assistance Publique-Hôpitaux de Paris, Groupe Henri-Mondor Albert-Chenevier, Service d'Immunologie Clinique, Créteil, France.
作者：
Yves,Lévy [1]
;
Christine,Lacabaratz [2]
;
Kim,Ellefsen-Lavoie [3]
;
Wolfgang,Stöhr [4]
;
Jean-Daniel,Lelièvre [1]
;
Pierre-Alexandre,Bart [3]
;
Odile,Launay [5]
;
Jonathan,Weber [6]
;
Bernd,Salzberger [7]
;
Aurélie,Wiedemann [2]
;
Mathieu,Surenaud [2]
;
David M,Koelle [8]
;
Hans,Wolf [7]
;
Ralf,Wagner [7]
;
Véronique,Rieux [9]
;
David C,Montefiori [10]
;
Nicole L,Yates [10]
;
Georgia D,Tomaras [10]
;
Raphael,Gottardo [11]
;
Bryan,Mayer [12]
;
Song,Ding [13]
;
Rodolphe,Thiébaut [14]
;
Sheena,McCormack [4]
;
Geneviève,Chêne [15]
;
Giuseppe,Pantaleo [16]
作者单位：
Vaccine Research Institute, Université Paris-Est Créteil, Faculté de Médecine, INSERM U955, équipe 16, Créteil, France.;Assistance Publique-Hôpitaux de Paris, Groupe Henri-Mondor Albert-Chenevier, Service d'Immunologie Clinique, Créteil, France.
[1]
Vaccine Research Institute, Université Paris-Est Créteil, Faculté de Médecine, INSERM U955, équipe 16, Créteil, France.
[2]
Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
[3]
MRC Clinical Trials Unit at UCL, London, United Kingdom.
[4]
Université de Paris, Faculté de médecine Paris Descartes; Inserm, CIC 1417, F-CRIN I-REIVAC; Assistance Publique-Hôpitaux de Paris, CIC Cochin Pasteur, Paris, France.
[5]
Imperial College London, London, United Kingdom.
[6]
University Hospital, Institute of Clinical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany.
[7]
Department of Medicine & Department of Global Health, University of Washington, Fred Hutchinson Cancer Research Center Seattle, Washington, United States of America.
[8]
Vaccine Research Institute, Université Paris-Est Créteil, Faculté de Médecine, INSERM U955, équipe 16, Créteil, France.;ANRS, Paris, France.
[9]
Department of Surgery, Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
[10]
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.;Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
[11]
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
[12]
EuroVacc Foundation, Lausanne, Switzerland.
[13]
Inserm, Bordeaux Population Health Research Center, UMR 1219, University Bordeaux, ISPED, CIC 1401-EC, Univ Bordeaux, Bordeaux, France.;CHU de Bordeaux, pôle de santé publique, Bordeaux, France.;INRIA SISTM, Talence, France.
[14]
Inserm, Bordeaux Population Health Research Center, UMR 1219, University Bordeaux, ISPED, CIC 1401-EC, Univ Bordeaux, Bordeaux, France.;CHU de Bordeaux, pôle de santé publique, Bordeaux, France.
[15]
Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.;Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
[16]
DOI
10.1371/journal.ppat.1008522
PMID
32589686
发布时间
2020-08-11
换一批
